Irregular and long menstrual cycles linked to greater risk of early death

September 30, 2020

Irregular and long menstrual cycles in adolescence and adulthood are associated with a greater risk of early death (before age 70), finds a study published by The BMJ today.

These associations were stronger for deaths related to cardiovascular disease and when long and irregular cycles were consistently present during adolescence and throughout adulthood. They were also slightly stronger among women who smoked.

The results highlight the need to consider the menstrual cycle as a vital sign of general health in women throughout their reproductive lifespan, say the researchers.

Irregular and long menstrual cycles are common among women of reproductive age and have been associated with a higher risk of major chronic diseases including ovarian cancer, coronary heart disease, type 2 diabetes, and mental health problems.

But evidence linking irregular or long menstrual cycles with mortality is scant.

So a team of researchers based in the USA set out to evaluate whether irregular or long menstrual cycles throughout the life course are associated with premature death (before age 70).

Their findings are based on data from 79,505 premenopausal women (average age 38 years) with no history of cardiovascular disease, cancer, or diabetes who were taking part in the Nurses' Health Study II.

Women reported the usual length and regularity of their menstrual cycles at ages 14-17 years, 18-22 years, and 29-46 years.

During 24 years of follow-up, 1,975 premature deaths were documented, including 894 from cancer and 172 from cardiovascular disease.

After taking account of other potentially influential factors, such as age, weight, lifestyle and family medical history, the researchers found that women who reported always having irregular menstrual cycles experienced higher mortality rates than women who reported very regular cycles in the same age ranges.

Mortality rates per 1,000 person years for women reporting very regular cycles and women reporting always irregular cycles were 1.05 and 1.23 at ages 14-17 years, 1.00 and 1.37 at ages 18-22 years, and 1.00 and 1.68 at ages 29-46 years.

Similarly, women who reported that their usual cycle length was 40 days or more at ages 18-22 years and 29-46 years were more likely to die prematurely than women who reported a usual cycle length of 26-31 days in the same age ranges.

These relations were strongest for deaths related to cardiovascular disease than for cancer or death from other causes. The higher mortality associated with long and irregular menstrual cycles was also slightly stronger among current smokers.

This is an observational study, so can't establish cause, and the researchers point to some limitations, such as relying on recall of menstrual cycle characteristics, which may not have been completely accurate, and the potential for other unmeasured factors to have affected their results.

Nevertheless, as it is not possible to randomise women to different menstrual cycle characteristics, studies like this one represent the strongest evidence possible for this question.

However, strengths included the large number of participants with a high follow-up rate over many years, and the availability of menstrual cycle data at three different points across the reproductive lifespan.

The researchers say the mechanisms underlying these associations are likely related to the disrupted hormonal environment. And they conclude that their results "emphasise the need for primary care providers to include menstrual cycle characteristics throughout the reproductive life span as additional vital signs in assessing women's general health status."
-end-
Peer reviewed? Yes

Evidence type: Observational

Subjects: Premenopausal women

BMJ

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.